COVID-19, even in mild cases, is linked to changes in Alzheimer’s disease-related brain biomarkers comparable to four years ...

Shares in Sorrento Therapeutics rose 158% on Friday after it revealed plans to start human trials of an antibody therapy that achieved complete inhibition of the coronavirus in preclinical studies.

COVID-19 has impacted nearly every aspect of life. Although tens of thousands of cases continue to occur each week, the world ...

The 86-patient CD10 trial looked at the antibody's potential in mild-to-moderate COVID-19, but failed to show a benefit on any measures, including the primary endpoint of "total clinical symptom ...

13 The sensitivity and specificity of the COVID-19 antibody assay were estimated to be 88.66% and 90.63%, respectively, based on the results for 397 infected cases and 128 non-SARS-CoV-2 infection ...

SG Americas Securities LLC purchased a new position in shares of OraSure Technologies, Inc. (NASDAQ:OSUR – Free Report) in the 4th quarter, Holdings Channel reports. The institutional investor ...

Teaming up to raise awareness of the continuing toll of COVID-19 in America, an ongoing mass disabling event causing an American death ...

Invivyd, Inc. is a microcap biotech company focusing on antibody-based treatments for infectious diseases like COVID-19.

The VDH and Scott are advocating for people to get their vaccinations before winter. Scott said he has received his COVID ...

The following is a summary of “Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain),” published in the January 2025 issue of Infectious Disease by Montagud et al ...